Civic Intelligence

Abzyme Research Foundation

990EZ • Fiscal year 2019 • EIN 27-3438658

Jan 01, 2019 to Dec 31, 2019 • Filed on Nov 09, 2020

67 Irving Place 12th FLNew York, NY 10003

(347) 967-3734

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

65th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2019 filings • NTEE H • <$500k nonprofits • Source year 2019

Liabilities / Revenue

65th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2019 filings • NTEE H • <$500k nonprofits • Source year 2019

Net Margin

77th percentile

46%

Higher net margin than 77% of similar nonprofits.

2019 filings • NTEE H • <$500k nonprofits • Source year 2019

Top Officer Pay

90th percentile

$0

Higher top officer pay than 90% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2019 filings • NTEE H • <$500k nonprofits • Source year 2019

Asset Growth

47th percentile

0.6%

Faster asset growth than 47% of similar nonprofits.

2019 filings • NTEE H • <$500k nonprofits • Annualized from 2018 to 2019

Revenue Growth

22nd percentile

-29%

Faster revenue growth than 22% of similar nonprofits.

2019 filings • NTEE H • <$500k nonprofits • Annualized from 2018 to 2019

Assets

Up

$353,342

Up $1,970 (+0.6%) from 2018

Net Assets

Up

$353,342

Up $12,720 (+3.7%) from 2018

Liabilities

Down

$0

Down $10,750 (-100%) from 2018

Revenue

Down

$60,108

Down $24,558 (-29%) from 2018

Expenses

Down

$32,293

Down $95,071 (-75%) from 2018

Net Income

Up

$27,815

Up $70,513 (+165%) from 2018

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$400K$300K$200K$100K$0Assets 2017: $385,535Liabilities 2017: $2,215Net Assets 2017: $383,3202017Assets 2018: $351,372Liabilities 2018: $10,750Net Assets 2018: $340,6222018Assets 2019: $353,342Liabilities 2019: $0Net Assets 2019: $353,3422019Assets 2020: $344,776Liabilities 2020: $0Net Assets 2020: $344,7762020Assets 2021: $341,865Liabilities 2021: $0Net Assets 2021: $341,8652021Assets 2022: $336,178Net Assets 2022: $336,1782022Assets 2023: $328,979Net Assets 2023: $328,9792023Assets 2024: $335,298Net Assets 2024: $335,2982024

Highlighted filing

2019

Assets$353,342
Liabilities$0
Net Assets$353,342

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$1.0M$500K$0-$500K-$1.0MRevenue 2017: $172,225Expenses 2017: $744,547Net Income 2017: -$572,3222017Revenue 2018: $84,666Expenses 2018: $127,364Net Income 2018: -$42,6982018Revenue 2019: $60,108Expenses 2019: $32,293Net Income 2019: $27,8152019Revenue 2020: $5,394Expenses 2020: $13,960Net Income 2020: -$8,5662020Revenue 2021: $139Expenses 2021: $3,050Net Income 2021: -$2,9112021Revenue 2022: $52Expenses 2022: $5,739Net Income 2022: -$5,6872022Revenue 2023: $23Expenses 2023: $7,223Net Income 2023: -$7,2002023Revenue 2024: $10,001Expenses 2024: $3,682Net Income 2024: $6,3192024

Highlighted filing

2019

Revenue$60,108
Expenses$32,293
Net Income$27,815
Jump To
Filing Snapshot
Filing Period
Jan 1, 2019 to Dec 31, 2019
Signed
Nov 9, 2020
Return Version
2019v5.1
Gross Receipts
$60,108
Mission and Program Overview

Mission

Advance the development of abzyme technology in the hopes of producing the world's first effective hiv vaccine and improved treatment for over 36 million hiv-positive people worldwide.

Program Services

DescriptionGrantsExpenses
THE SUCCESSFUL COMPLETION OF THE PRE-INVESTIGATIONAL NEW DRUG MEETING WITH THE FDA. AS WELL AS THE INITIATION OF A SCALE-UP OF THE MANUFACTURING OF THE VACCINE COMPOUND.$0$18,873
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
ADAM MACLEANChair-$0--
MICHAEL JEFVERTVice Chair-$0--
NICHOLAS SMITHTreasurer-$0--
AIMEE A DROUINSecretary-$0--
ZACHARY BARNETTExecutive DirectorFT$0--
VALERIE KERRDirector-$0--
BETH MILLER SAKSDirector-$0--
TIM VOLKDirector-$0--
Filing and Contact Details

Filer

Filer Name
Abzyme Research Foundation
EIN
27-3438658
Phone
3479673734
Address
67 IRVING PLACE 12TH FL, NEW YORK, NY 10003

Signing Officer

Name
Zachary Barnett
Title
Executive Director
Phone
3479673734
Signed
2020-11-09
Discuss with paid preparer
Yes

Preparer

Firm
Skody Scot & Co Cpas Pc
Address
520 EIGHTH AVE SUITE 2200, NEW YORK, NY 10018
Preparer
Laurence Scot Mba CPA
Phone
2129671100
Supplemental Narrative

Additional Explanations

Form 990-ez, Part I, Line 4 - Other Investment Income

Description: interest. Amount: 24.

Form 990-ez, Part I, Line 16 - Other Expenses

Description: insurance. Amount: 1,931. Description: travel and meetings. Amount: 3,965. Description: office expenses. Amount: 50. Description: dues and subscriptions. Amount: 2,542. Description: bank fees and processing charges. Amount: 101. Total to form 990-ez, line 16: 8,589.

Form 990-ez, Part I, Line 20 - Other Changes in Net Assets

Description: prior period adjustment. Amount: -15,095.

Form 990-ez, Part II, Line 24 - Other Assets

Description: contributions receivable. Beg. Of year amount: 25,000. End of year amount: 0. Description: investment in covalent bioscience. Beg. Of year amount: 265,658. End of year amount: 265,658.

Form 990-ez, Part II, Line 26 - Other Liabilities

Description: accounts payable and accrued expenses. Beg. Of year amount: 10,750. End of year amount: 0.

Raw XML Appendix198 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd00
IRS990EZ/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0THE ORGANIZATION
IRS990EZ/BooksInCareOfDetail/PhoneNum03479673734
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt067 IRVING PLACE 12TH FL
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0NEW YORK
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0NY
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd010003
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt060714
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt087684
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd00
IRS990EZ/ContributionsGiftsGrantsEtcAmt060084
IRS990EZ/DirectIndirectPltclExpendAmt00
IRS990EZ/DonorAdvisedFndsInd00
IRS990EZ/EngagedInExcessBenefitTransInd00
IRS990EZ/ExcessOrDeficitForYearAmt027815
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt022775
IRS990EZ/FiledScheduleAInd01
IRS990EZ/ForeignFinancialAccountInd00
IRS990EZ/ForeignOfficeInd00
IRS990EZ/Form990TotalAssetsGrp/BOYAmt0351372
IRS990EZ/Form990TotalAssetsGrp/EOYAmt0353342
IRS990EZ/GrossReceiptsAmt060108
IRS990EZ/InfoInScheduleOPartIIIInd0X
IRS990EZ/InfoInScheduleOPartIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/InfoInScheduleOPartVInd0X
IRS990EZ/InvestmentIncomeAmt024
IRS990EZ/LobbyingActivitiesInd00
IRS990EZ/MadeLoansToFromOfficersInd00
IRS990EZ/MethodOfAccountingCashInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt0340622
IRS990EZ/NetAssetsOrFundBalancesEOYAmt0353342
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt0340622
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt0353342
IRS990EZ/OccupancyRentUtltsAndMaintAmt0590
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt04.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt11.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt21.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt31.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt450.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt51.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt61.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt71.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt60
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt70
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt60
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt70
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt60
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt70
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0ADAM MACLEAN
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1MICHAEL JEFVERT
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2NICHOLAS SMITH
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3AIMEE A DROUIN
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm4ZACHARY BARNETT
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm5VALERIE KERR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm6BETH MILLER SAKS
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm7TIM VOLK
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0CHAIR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1VICE CHAIR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2TREASURER
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3SECRETARY
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt4EXECUTIVE DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt5DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt6DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt7DIRECTOR
IRS990EZ/OperateHospitalInd00
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd00
IRS990EZ/OrganizationHadUBIInd00
IRS990EZ/OtherAssetsTotalDetail/BOYAmt0290658
IRS990EZ/OtherAssetsTotalDetail/EOYAmt0265658
IRS990EZ/OtherChangesInNetAssetsAmt0-15095
IRS990EZ/OtherExpensesTotalAmt08589
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd00
IRS990EZ/PrimaryExemptPurposeTxt0ADVANCE THE DEVELOPMENT OF ABZYME TECHNOLOGY IN THE HOPES OF PRODUCING THE WORLD'S FIRST EFFECTIVE HIV VACCINE AND IMPROVED TREATMENT FOR OVER 36 MILLION HIV-POSITIVE PEOPLE WORLDWIDE.
IRS990EZ/PrintingPublicationsPostageAmt0101
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0THE SUCCESSFUL COMPLETION OF THE PRE-INVESTIGATIONAL NEW DRUG MEETING WITH THE FDA. AS WELL AS THE INITIATION OF A SCALE-UP OF THE MANUFACTURING OF THE VACCINE COMPOUND.
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt00
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt018873
IRS990EZ/ProhibitedTaxShelterTransInd00
IRS990EZ/RelatedOrganizationCtrlEntInd00
IRS990EZ/SalariesOtherCompEmplBnftAmt0238
IRS990EZ/SchoolOperatingInd00
IRS990EZ/StatesWhereCopyOfReturnIsFldCd0NY
IRS990EZ/SubjectToProxyTaxInd00
IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt010750
IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt00
IRS990EZ/TanningServicesProvidedInd00
IRS990EZ/TaxImposedOnOrganizationMgrAmt00
IRS990EZ/TaxImposedUnderIRC4911Amt00
IRS990EZ/TaxImposedUnderIRC4912Amt00
IRS990EZ/TaxImposedUnderIRC4955Amt00
IRS990EZ/TaxReimbursedByOrganizationAmt00
IRS990EZ/TotalExpensesAmt032293
IRS990EZ/TotalProgramServiceExpensesAmt018873
IRS990EZ/TotalRevenueAmt060108
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd00
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0WWW.ENDHIV.COM
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt060084
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt084615
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt0142070
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt01097580
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt0441682
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt01826031
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt024
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt051
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt0155
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt034
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt08
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt0272
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.57940
IRS990ScheduleA/PublicSupportPY170Pct00.61140
IRS990ScheduleA/PublicSupportTotal170Amt01058213
IRS990ScheduleA/SubstantialContributorsTotAmt0767818
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt060084
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt084615
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt0142070
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt01097580
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt0441682
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt01826031
IRS990ScheduleA/TotalSupportAmt01826303
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0DESCRIPTION: INTEREST. AMOUNT: 24.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1DESCRIPTION: INSURANCE. AMOUNT: 1,931. DESCRIPTION: TRAVEL AND MEETINGS. AMOUNT: 3,965. DESCRIPTION: OFFICE EXPENSES. AMOUNT: 50. DESCRIPTION: DUES AND SUBSCRIPTIONS. AMOUNT: 2,542. DESCRIPTION: BANK FEES AND PROCESSING CHARGES. AMOUNT: 101. TOTAL TO FORM 990-EZ, LINE 16: 8,589.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2DESCRIPTION: PRIOR PERIOD ADJUSTMENT. AMOUNT: -15,095.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3DESCRIPTION: CONTRIBUTIONS RECEIVABLE. BEG. OF YEAR AMOUNT: 25,000. END OF YEAR AMOUNT: 0. DESCRIPTION: INVESTMENT IN COVALENT BIOSCIENCE. BEG. OF YEAR AMOUNT: 265,658. END OF YEAR AMOUNT: 265,658.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4DESCRIPTION: ACCOUNTS PAYABLE AND ACCRUED EXPENSES. BEG. OF YEAR AMOUNT: 10,750. END OF YEAR AMOUNT: 0.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990-EZ, PART I, LINE 4 - OTHER INVESTMENT INCOME
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990-EZ, PART I, LINE 16 - OTHER EXPENSES
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990-EZ, PART I, LINE 20 - OTHER CHANGES IN NET ASSETS
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990-EZ, PART II, LINE 24 - OTHER ASSETS
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4FORM 990-EZ, PART II, LINE 26 - OTHER LIABILITIES
TransferPrsnlBnftContractsDecl/DeclarationDesc0THE ORGANIZATION DID NOT, DURING THE YEAR, RECEIVE ANY FUNDS, DIRECTLY,OR INDIRECTLY, TO PAY PREMIUMS ON A PERSONAL BENEFIT CONTRACT.THE ORGANIZATION, DID NOT, DURING THE YEAR, PAY ANY PREMIUMS, DIRECTLY,OR INDIRECTLY, ON A PERSONAL BENEFIT CONTRACT.
ReturnHeader/BuildTS02021-01-29 14:40:06Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd01
ReturnHeader/BusinessOfficerGrp/PersonNm0ZACHARY BARNETT
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0EXECUTIVE DIRECTOR
ReturnHeader/BusinessOfficerGrp/PhoneNum03479673734
ReturnHeader/BusinessOfficerGrp/SignatureDt02020-11-09
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0ABZYME RESEARCH FOUNDATION
ReturnHeader/Filer/BusinessNameControlTxt0ABZY
ReturnHeader/Filer/EIN0273438658
ReturnHeader/Filer/PhoneNum03479673734
ReturnHeader/Filer/USAddress/AddressLine1Txt067 IRVING PLACE 12TH FL
ReturnHeader/Filer/USAddress/CityNm0NEW YORK
ReturnHeader/Filer/USAddress/StateAbbreviationCd0NY
ReturnHeader/Filer/USAddress/ZIPCd010003
ReturnHeader/FilingSecurityInformation/AtSubmissionCreationDeviceId095362FB61C2BFCAB3B9855A80F88891215CDFAB4
ReturnHeader/FilingSecurityInformation/AtSubmissionFilingDeviceId095362FB61C2BFCAB3B9855A80F88891215CDFAB4
ReturnHeader/FilingSecurityInformation/FilingLicenseTypeCd0P
ReturnHeader/FilingSecurityInformation/IPAddress/IPv4AddressTxt038.122.225.90
ReturnHeader/FilingSecurityInformation/IPDt02020-11-09
ReturnHeader/FilingSecurityInformation/IPTimezoneCd0ES
ReturnHeader/FilingSecurityInformation/IPTm012:03:02
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0133597814
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0SKODY SCOT & CO CPAS PC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt0520 EIGHTH AVE SUITE 2200
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0NEW YORK
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0NY
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd010018
ReturnHeader/PreparerPersonGrp/PhoneNum02129671100
ReturnHeader/PreparerPersonGrp/PreparationDt02020-11-09
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0LAURENCE SCOT MBA CPA
ReturnHeader/ReturnTs02020-11-09T11:03:54-06:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02019-01-01
ReturnHeader/TaxPeriodEndDt02019-12-31
ReturnHeader/TaxYr02019

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings